by Eric Christianson | Dec 20, 2023 | Drug Interaction Case Studies and Education For Pharmacists
I recently came across a clinical issue in my practice as a consultant pharmacist to assisted living and long-term care facilities. The item in question was how to manage the apixaban diltiazem interaction. Apixaban Diltiazem Interaction Defined Apixaban is...
by Eric Christianson | Oct 29, 2023 | Drug Interaction Case Studies and Education For Pharmacists
How many times have you picked up, dispensed, or seen an auxiliary label on a medication encouraging you to avoid alcohol while taking it? It’s definitely information that could come up on a board exam at some point throughout your career! Below is a table...
by Eric Christianson | Jul 30, 2023 | Drug Interaction Case Studies and Education For Pharmacists
After my recent post on my top 5 medication/vitamin interactions, I received the request to cover medications that deplete vitamins and minerals. I loved this idea because it is an important consideration in clinical practice! Keep in mind that these often show up on...
by Eric Christianson | Jul 9, 2023 | Drug Interaction Case Studies and Education For Pharmacists
Patients use numerous supplements that contain vitamins. I outline my top 5 vitamin drug interactions in this post and how they may impact patient care. Vitamin K and Warfarin The first vitamin drug interaction you could probably guess. Vitamin K intake affects...
by Eric Christianson | May 10, 2023 | Drug Interaction Case Studies and Education For Pharmacists
In this case study, I highlight the clinical impact that the ciprofloxacin and zolpidem interaction can have on a patient. JS is a 58-year-old female with a history of insomnia and takes zolpidem 10 mg at bedtime every night. She has recently been diagnosed with a...
by Eric Christianson | Apr 19, 2023 | Cardiovascular Medication and Disease State Clinical Pearls, Drug Interaction Case Studies and Education For Pharmacists
Beta-blockers are a class of medication that is frequently used for cardiac and cardiovascular purposes. Selectivity and evidence of benefit often guide selection, but one thing that may get overlooked is beta-blocker interactions in relation to CYP enzymes. Not all...
